COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
SNORD116@ |
|
small nucleolar RNA, C/D box 116 cluster
|
|
|
0.705 |
0.692 |
PTLS |
|
Potocki-Lupski syndrome
|
|
|
0.780 |
0.308 |
ARNTL |
O00327
|
aryl hydrocarbon receptor nuclear translocator like
|
Transcription factor
|
0.99 |
0.510 |
0.885 |
MEIS1 |
O00470
|
Meis homeobox 1
|
Enzyme
|
1.00 |
0.579 |
0.615 |
MCF2L |
O15068
|
MCF.2 cell line derived transforming sequence like
|
Signaling
|
2.7E-07 |
0.559 |
0.769 |
CLOCK |
O15516
|
clock circadian regulator
|
|
1.00 |
0.463 |
0.885 |
HCRT |
O43612
|
hypocretin neuropeptide precursor
|
|
2.9E-02 |
0.500 |
0.808 |
PLXNA2 |
O75051
|
plexin A2
|
|
1.1E-06 |
0.447 |
0.808 |
PSIP1 |
O75475
|
PC4 and SFRS1 interacting protein 1
|
Signaling
|
1.00 |
0.490 |
0.846 |
REM1 |
O75628
|
RRAD and GEM like GTPase 1
|
|
5.3E-08 |
0.531 |
0.885 |
CDKL5 |
O76039
|
cyclin dependent kinase like 5
|
Kinase
|
1.00 |
0.522 |
0.692 |
CA1 |
P00915
|
carbonic anhydrase 1
|
|
4.7E-11 |
0.623 |
0.769 |
CST3 |
P01034
|
cystatin C
|
|
3.9E-03 |
0.436 |
0.808 |
AVP |
P01185
|
arginine vasopressin
|
Signaling
|
7.4E-02 |
0.437 |
0.846 |
HLA-DQB1 |
P01920
|
major histocompatibility complex, class II, DQ beta 1
|
Immune response
|
8.9E-03 |
0.407 |
0.885 |
APOE |
P02649
|
apolipoprotein E
|
|
1.9E-03 |
0.338 |
0.962 |
CRP |
P02741
|
C-reactive protein
|
|
3.7E-03 |
0.299 |
0.962 |
GC |
P02774
|
GC vitamin D binding protein
|
Transporter
|
2.7E-11 |
0.489 |
0.885 |
NR3C1 |
P04150
|
nuclear receptor subfamily 3 group C member 1
|
Nuclear receptor
|
0.97 |
0.393 |
0.885 |
IGF1 |
P05019
|
insulin like growth factor 1
|
|
0.27 |
0.318 |
0.885 |
ALDH2 |
P05091
|
aldehyde dehydrogenase 2 family member
|
Enzyme
|
3.4E-10 |
0.457 |
0.885 |
IL6 |
P05231
|
interleukin 6
|
|
0.32 |
0.248 |
0.962 |
HLA-DQB2 |
P05538
|
major histocompatibility complex, class II, DQ beta 2
|
Immune response
|
4.3E-02 |
0.573 |
0.731 |
BCHE |
P06276
|
butyrylcholinesterase
|
|
1.1E-13 |
0.447 |
0.923 |